43 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp00979 | Adenoregulin | GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV | South American frog, Giant leaf frog | Cell membrane disintegration | LDH leakage assay | PC-3 | Prostate cancer | GI50 : 1.24 ± 0.23 µM |
| dbacp00980 | Adenoregulin | GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV | South American frog, Giant leaf frog | Cell membrane disintegration | LDH leakage assay | LNCaP | Prostate cancer | GI50 : 0.31 ± 0.15 µM |
| dbacp00981 | Adenoregulin | GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV | South American frog, Giant leaf frog | Cell membrane disintegration | LDH leakage assay | DU-145 | Liver cancer | GI50 : 0.91 ± 0.04 µM |
| dbacp00982 | Adenoregulin | GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV | South American frog, Giant leaf frog | Cell membrane disintegration | LDH leakage assay | MDA-MB-231 | Breast cancer | GI50 : 8.06 ± 0.50 µM |
| dbacp00983 | Adenoregulin | GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV | South American frog, Giant leaf frog | Cell membrane disintegration | LDH leakage assay | Raji | Lymphoma cancer | GI50 : 2.57 ± 0.75 µM |
| dbacp02334 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Silkmoth | Membrane disruption | LDH leakage assay | 486P | Bladder cancer | IC50 : 373.3/ µg/ml |
| dbacp02335 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Silkmoth | Membrane disruption | LDH leakage assay | RT4 | Bladder cancer | IC50 : 289.3 µg/ml |
| dbacp02336 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Silkmoth | Membrane disruption | LDH leakage assay | 647V | Bladder cancer | IC50 : 200.7 µg/ml |
| dbacp02337 | Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK | Silkmoth | Membrane disruption | LDH leakage assay | J82 | Bladder cancer | IC50 : 319.2 µg/ml |
| dbacp02353 | Cecropin B | KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL | Chinese oak silk moth | Membrane disruption | LDH leakage assay | 486P | Bladder cancer | IC50 : 232.4 µg/ml |
| dbacp02354 | Cecropin B | KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL | Chinese oak silk moth | Membrane disruption | LDH leakage assay | RT4 | Bladder cancer | IC50 : 240.4 µg/ml |
| dbacp02355 | Cecropin B | KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL | Chinese oak silk moth | Membrane disruption | LDH leakage assay | 647V | Bladder cancer | IC50 : 181.1 µg/ml |
| dbacp02356 | Cecropin B | KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL | Chinese oak silk moth | Membrane disruption | LDH leakage assay | J82 | Bladder cancer | Cytotoxicity : 196.3 µg/ml |
| dbacp03305 | HIV-TAT48-57 | GRKKRRQRRR | Not found | Apoptosis inducing | LDH leakage assay | HeLa | Cervical cancer | 7% apoptosis at 10 µM |
| dbacp03306 | HIV-TAT48-57 | GRKKRRQRRR | Not found | Apoptosis inducing | LDH leakage assay | HeLa | Cervical cancer | 15% apoptosis at 20 µM |
| dbacp03307 | HIV-TAT48-57 | GRKKRRQRRR | Not found | Apoptosis inducing | LDH leakage assay | HeLa | Cervical cancer | 35% apoptosis at 30 µM |
| dbacp03308 | HIV-TAT48-57 | GRKKRRQRRR | Not found | Apoptosis inducing | LDH leakage assay | HeLa | Cervical cancer | 65% apoptosis at 50 µM |
| dbacp03705 | Latarcin 2a | GLFGKLIKKFGRKAISYAVKKARGKH | Central Asian spider | Membrane disruption | LDH leakage assay | Breast tumor cell line | Breast cancer | Not found |
| dbacp04295 | ltc2aG11A | GLFGKLIKKFARKAISYAVKKARGKH | Central Asian spider | Membrane disruption | LDH leakage assay | Prostate tumor cell line | Prostate cancer | Not found |
| dbacp04477 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Membrane perforation | LDH leakage assay | RT4(G1) | Bladder cancer | IC50 : 32.3 µM |
| dbacp04478 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Membrane perforation | LDH leakage assay | 647V(G2) | Bladder cancer | IC50 : 54.1 µM |
| dbacp04479 | Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS | African clawed frog | Membrane perforation | LDH leakage assay | 486P(G4) | Bladder cancer | IC50 : 28.6 µM |
| dbacp06215 | TAT-Ras-GAP317-326 | GRKKRRQRRRGGWMWVTNLRTD | Not found | Apoptosis inducing | LDH leakage assay | HeLa | Cervical cancer | 15% apoptosis at 10 µM |
| dbacp06216 | TAT-Ras-GAP317-326 | GRKKRRQRRRGGWMWVTNLRTD | Not found | Apoptosis inducing | LDH leakage assay | HeLa | Cervical cancer | 47% apoptosis at 20 µM |
| dbacp06217 | TAT-Ras-GAP317-326 | GRKKRRQRRRGGWMWVTNLRTD | Not found | Apoptosis inducing | LDH leakage assay | HeLa | Cervical cancer | 72% apoptosis at 30 µM |
| dbacp06218 | TAT-Ras-GAP317-326 | GRKKRRQRRRGGWMWVTNLRTD | Not found | Apoptosis inducing | LDH leakage assay | HeLa | Cervical cancer | 79% apoptosis at 50 µM |
| dbacp06232 | Temporin-1CEa | FVDLKKIANIINSIF | Chinese brown frog | Membrane disruption | LDH leakage assay | MDA-MB-231 | Breast cancer | 61% cytotoxicity at 40 µM |
| dbacp06234 | Temporin-1CEa | FVDLKKIANIINSIF | Chinese brown frog | Membrane disruption | LDH leakage assay | MCF-7 | Breast cancer | 32% cytotoxicity at 40 µM |
| dbacp06236 | Temporin-1CEa | FVDLKKIANIINSIF | Chinese brown frog | Membrane disruption | LDH leakage assay | MDA-MB-231 | Breast cancer | MIC : 40 µM |
| dbacp06238 | Temporin-1CEa | FVDLKKIANIINSIF | Chinese brown frog | Membrane disruption | LDH leakage assay | MCF-7 | Breast cancer | MIC : 40 µM |
| dbacp06753 | Salamandrin - I | FAVWGCADYRGY | Salamandra salamandra | Pyroptosis mediated | LDH leakage assay | HL-60 | Leukemia Cancer | Absorbance ~ 2 at 490 nm at 27 27 µM |
| dbacp06792 | PS9 | PSRKVMLWS | Aphanomyces invadans | Reactive Oxygen Species and Apoptotic Pathways | LDH leakage assay | MCF-7 | Breast Cancer | 71.25 ± 1.3% LDH release at 40 μM |
| dbacp06797 | LHRH-BinBC | QHWSYGLRPGGRGPKDAVRAVKGSALLPCIIVHDPNLNNSDKMKFNTYYLLEYKEYWHQLWSQIIPAHQTVKIQERTGISEVVQNSMIEDLNMYIGADFGMYFYLRSSGFKEQITRGLNRPLSQTTTQLGERVEEMEYYNSNDLDVRYVKYALAREFTLKRVNGEIVKNWVAVDYRMAGIQSYPNAPITNPLTLT | Synthetic | Apoptosis inducing | LDH leakage assay | MCF-7 | Breast Cancer | 40% LDH efflux at 16 µM |
| dbacp06940 | PS14 | PTECQVGTTCKVES | Aphanomyces invadans | Not available | LDH leakage assay | Hep-2 | Larynx Cancer | 45.56 ± 2% LDH release at 20 µM |
| dbacp07516 | Dermaseptin-PP | ALWKDMLKGIGKLAGKAALGAVKTLV | Phyllomedusa palliata | Membrane disruption triggers dual apoptosis | LDH leakage assay | H-157 | Lung Cancer | 80% LDH release at 10−4 M |
| dbacp08137 | Laterosporulin10 (LS10) | ACVNQCPDAIDRFIVKDKGCHGVEKKYYKQVYVACMNGQHLYCRTEGGPCQL | Brevibacillus sp. strain SKDU10 | Apoptosis inducing | LDH leakage assay | MCF-7 | Breast Cancer | >80% LDH release at 15 μM |
| dbacp08141 | Laterosporulin10 (LS10) | ACVNQCPDAIDRFIVKDKGCHGVEKKYYKQVYVACMNGQHLYCRTEGGPCQL | Brevibacillus sp. strain SKDU10 | Apoptosis inducing | LDH leakage assay | HeLa | Cervical Cancer | ~80% LDH release at 15 μM |
| dbacp08151 | ZXR-2 | FKIGGFIKKLWRSLLA | Synthetic | Ile/Leu residues crucially mediate cytolysis | LDH leakage assay | HeLa | Cervical Cancer | 40% LDH release at 32 μM |
| dbacp08154 | IL-1 | FKAGGFIKKLWRSLLA | Synthetic | Ile/Leu residues crucially mediate cytolysis | LDH leakage assay | HeLa | Cervical Cancer | 30% LDH release at 32 μM |
| dbacp08157 | IL-2 | FKIGGFAKKLWRSLLA | Synthetic | Ile/Leu residues crucially mediate cytolysis | LDH leakage assay | HeLa | Cervical Cancer | 30% LDH release at 32 μM |
| dbacp08160 | IL-3 | FKIGGFIKKAWRSLLA | Synthetic | Ile/Leu residues crucially mediate cytolysis | LDH leakage assay | HeLa | Cervical Cancer | 35% LDH release at 32 μM |
| dbacp08163 | IL-4 | FKIGGFIKKLWRSALA | Synthetic | Ile/Leu residues crucially mediate cytolysis | LDH leakage assay | HeLa | Cervical Cancer | 28% LDH release at 32 μM |
| dbacp08166 | IL-5 | FKIGGFIKKLWRSLAA | Synthetic | Ile/Leu residues crucially mediate cytolysis | LDH leakage assay | HeLa | Cervical Cancer | 35% LDH release at 32 μM |